Dietary supplement use, physical activity, body mass index, and pancreatic cancer
膳食补充剂的使用、体力活动、体重指数和胰腺癌
基本信息
- 批准号:7790549
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-04-01 至 2012-03-31
- 项目状态:已结题
- 来源:
- 关键词:18 year oldAddressAdultAffectAgeAmericanAnti-Inflammatory AgentsAnti-inflammatoryAntioxidantsAreaAscorbic AcidBehavioralBenefits and RisksBeta CaroteneBody WeightBody mass indexBotanicalsCancer EtiologyCancer PrognosisCaroteneCatchment AreaCessation of lifeCohort StudiesCountryCountyDataData AnalysesDevelopmentDiagnosisDietDietary ComponentDiseaseEnvironmental ExposureEpidemiologic StudiesFolateFundingGinkgo bilobaGoalsHealthHigh PrevalenceIncidenceIndividualInflammationIntakeInvestigationIronKnowledgeLifeLife StyleLinkMalignant NeoplasmsMalignant neoplasm of pancreasMeasuresMethodsMineralsMultivitaminNational Cancer InstituteNon-Insulin-Dependent Diabetes MellitusNutrientObesityOmega-3 Fatty AcidsOut-MigrationsOxidative StressParticipantPharmaceutical PreparationsPhysical activityPilot ProjectsPreventionPropertyPublic HealthQuestionnairesRecording of previous eventsRecruitment ActivityRegistriesRelative (related person)ResourcesRiskRisk FactorsRoleSeleniumStagingSurvival RateSystemTimeUnited StatesVariantVitamin EVitaminsWashingtonWomanagedanticancer researchbasecancer riskcase controlchronic pancreatitiscigarette smokingcohortconventional therapydietary supplementsdosageenergy balanceepidemiologic datafollow-upinterestlycopenemembermenmodifiable riskneoplasm registrynon-drugoutcome forecastpreventprotective effectpublic health relevance
项目摘要
DESCRIPTION (provided by applicant): Pancreatic cancer is the fourth most common cause of cancer deaths in the United States (U.S.), has a very poor prognosis, and is generally unresponsive to conventional therapies. Therefore, it is critical to identify modifiable factors that can be used in prevention efforts to reduce risk for developing this disease. Diet, physical activity, and obesity have been postulated to potentially influence pancreatic cancer risk, but results are inconsistent. Also, millions of Americans use dietary (vitamin, mineral, and herbal) supplements to prevent cancer and other diseases, but with few exceptions, there is sparse evidence for either their benefits or risks. Specific Aims The goal of this study is to examine associations of various dietary supplements with pancreatic cancer incidence, using previously collected data from a large cohort study with a high proportion of supplement users. The primary specific aims are to investigate associations of supplemental intakes of nutrients with anti-inflammatory (vitamin E, selenium, and omega-3 fatty acids) and antioxidant properties (vitamin C, vitamin E, beta-carotene, lycopene, and selenium) over the 10-year period ending at baseline with the incidence of pancreatic cancer. Secondary aims are to examine associations of intakes of specific, less common vitamin, mineral, botanical, and other supplements (e.g., folate, iron, gingko biloba) and non- steroidal anti-inflammatory drugs (NSAIDs); as well as physical activity and body mass index levels at baseline and ages 18, 30, and 45 years with pancreatic cancer incidence. Methods Between 2000-2002, 77,738 men and women, aged 50-76 from western Washington State completed a baseline questionnaire that captured detailed information on use of 38 supplements over the previous 10 years, diet, physical activity (using a validated questionnaire), anthropometrics, health history, and cancer risk factors. Supplement users were targeted in recruitment; therefore, supplement use by cohort members is both high and of long duration: 79% were ever users of a supplement, and 66% used multivitamins,46% used individual vitamin C, and 47% used individual vitamin E, typically for 5-8 of the previous 10years. The cohort is being followed for pancreatic cancers by linkage to the western Washington SEER cancer registry, deaths by linkage to the Washington State death file, and out-migration from the SEER catchment area by linkage to the National Change of Address system. This proposal seeks funds to conduct analyses addressing the specific aims. We expect to identify 215 pancreatic cancer cases after a mean follow-up of 8.3 years. The primary exposure would be average intake per day over the previous 10 years of the nutrient of interest (single supplements plus multivitamins), and all analyses will be adjusted for diet and other potential confounders and effect modifiers. Significance The results of this study will be one of the first to examine associations of dietary supplement use, as well as physical activity and obesity, with risk for pancreatic cancer, a disease with a high fatality rate and few known modifiable risk factors. We would use data from the only cohort study specifically focused on the etiologic relationships of dietary supplements with cancer risk which carefully measured supplement use and confounding factors. Importantly, given the high prevalence of dietary supplement use in the U.S., our findings will have important public health implications regardless of whether we find protective effects, increased risks, or no effects of supplements on pancreatic cancer risk. PUBLIC HEALTH RELEVANCE: Pancreatic cancer is a highly fatal disease for which there are few known modifiable risk factors. It has been suggested that diet, physical activity, and obesity may impact pancreatic cancer development, but results are inconsistent. Also, many Americans use dietary (vitamin, mineral, and herbal) supplements with limited knowledge regarding their potential benefits and risks. The goal of this proposed study is to examine associations of various dietary supplements, as well as physical activity and body mass index levels at baseline and ages 18, 30, and 45 years, with pancreatic cancer incidence. To accomplish these aims, we would conduct secondary data analyses within a large cohort of men and women (n=77,738), 50-76 years (at baseline) in western Washington state. Cohort members completed a detailed baseline questionnaire covering supplement use over the past 10 years, diet, physical activity, anthropometrics, health history, and cancer risk factors. An expected 215 pancreatic cancer cases would be identified after a mean follow-up of 8.3 years by linkage to the western Washington SEER cancer registry. This proposed project would provide valuable information regarding whether use of dietary supplements, as well as physical activity and body mass index are associated with pancreatic cancer incidence, and would be useful for the millions of American adults who take supplements, regardless of whether protective effects, no effects, or increased risks for specific supplements are found.
描述(由申请人提供):胰腺癌是美国癌症死亡的第四大常见原因,预后非常差,通常对常规治疗无反应。因此,确定可用于预防工作的可改变因素以降低患此病的风险至关重要。饮食、体育活动和肥胖被认为可能影响胰腺癌的风险,但结果并不一致。此外,数以百万计的美国人使用膳食补充剂(维生素、矿物质和草药)来预防癌症和其他疾病,但除了少数例外,很少有证据表明它们的益处或风险。本研究的目的是研究各种膳食补充剂与胰腺癌发病率的关系,使用先前从一项大型队列研究中收集的数据,该研究中有高比例的补充剂使用者。主要的具体目的是调查在基线结束的10年期间补充摄入具有抗炎(维生素E、硒和omega-3脂肪酸)和抗氧化特性(维生素C、维生素E、β -胡萝卜素、番茄红素和硒)的营养素与胰腺癌发病率之间的关系。次要目的是检查特定的、不常见的维生素、矿物质、植物和其他补充剂(如叶酸、铁、银杏叶)和非甾体抗炎药(NSAIDs)的摄入量之间的关系;以及18岁,30岁和45岁胰腺癌患者的身体活动和体重指数水平。方法2000-2002年间,来自华盛顿州西部的77,738名年龄在50-76岁之间的男性和女性完成了一份基线问卷,该问卷收集了过去10年38种补充剂的使用情况、饮食、体育活动(使用有效问卷)、人体测量学、健康史和癌症风险因素的详细信息。补充用户的招募有针对性;因此,队列成员服用补充剂的时间既高又长:79%的人曾经服用过补充剂,66%的人服用复合维生素,46%的人服用单一维生素C, 47%的人服用单一维生素E,通常在过去10年的5-8年。该队列通过与西华盛顿SEER癌症登记处的联系来跟踪胰腺癌,通过与华盛顿州死亡档案的联系来跟踪死亡,并通过与国家地址变更系统的联系来跟踪从SEER集水区向外迁移的队列。这项建议寻求资金进行针对具体目标的分析。我们期望在平均8.3年的随访后确定215例胰腺癌病例。主要暴露量是研究对象在过去10年里每天的平均摄入量(单一补充剂加上多种维生素),所有的分析都将根据饮食和其他潜在的混杂因素和影响调节因素进行调整。这项研究的结果将是第一个研究膳食补充剂使用、体育活动和肥胖与胰腺癌风险之间关系的研究之一,胰腺癌是一种死亡率高、已知可改变的风险因素很少的疾病。我们将使用唯一一项队列研究的数据,该研究特别关注膳食补充剂与癌症风险的病因学关系,仔细测量了补充剂的使用情况和混杂因素。重要的是,鉴于膳食补充剂在美国的高流行率,我们的研究结果将具有重要的公共卫生意义,无论我们是否发现补充剂对胰腺癌风险的保护作用、增加风险或没有影响。公共卫生相关性:胰腺癌是一种高度致命的疾病,很少有已知的可改变的危险因素。有人认为饮食、体育活动和肥胖可能影响胰腺癌的发展,但结果并不一致。此外,许多美国人在使用膳食补充剂(维生素、矿物质和草药)时,对其潜在的益处和风险知之甚少。本研究的目的是研究各种膳食补充剂,以及18岁、30岁和45岁时的身体活动和体重指数水平与胰腺癌发病率的关系。为了实现这些目标,我们将在华盛顿州西部50-76岁(基线)的大型男性和女性队列(n=77,738)中进行二次数据分析。队列成员完成了一份详细的基线问卷,包括过去10年的补充剂使用情况、饮食、身体活动、人体测量、健康史和癌症风险因素。通过与西华盛顿SEER癌症登记处的联系,预计在平均8.3年的随访后,将确定215例胰腺癌病例。这项计划将提供关于膳食补充剂的使用、身体活动和体重指数是否与胰腺癌发病率相关的有价值的信息,并将对数百万服用补充剂的美国成年人有用,无论是否发现特定补充剂的保护作用、无作用或增加风险。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ka Kahe其他文献
Ka Kahe的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ka Kahe', 18)}}的其他基金
Radon exposure in relation to the risk of cognitive impairment and mitochondrial function
氡暴露与认知障碍和线粒体功能风险相关
- 批准号:
10591204 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Residential Radon Exposure and Stroke Risk: the REGARDS Study
住宅氡暴露和中风风险:REGARDS 研究
- 批准号:
10599123 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Trace mineral levels, metabolomics, and diabetes risk
微量矿物质水平、代谢组学和糖尿病风险
- 批准号:
9984764 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Trace mineral levels, the trajectory of cognitive decline and telomere attrition
微量矿物质水平、认知能力下降和端粒磨损的轨迹
- 批准号:
9332844 - 财政年份:2017
- 资助金额:
-- - 项目类别:
Dietary supplement use, physical activity, body mass index, and pancreatic cancer
膳食补充剂的使用、体力活动、体重指数和胰腺癌
- 批准号:
8055989 - 财政年份:2009
- 资助金额:
-- - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
-- - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
-- - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant














{{item.name}}会员




